184 - Modernizing Antiviral Dosing Strategies

Friday, October 13, 2023

3:15 PM – 4:30 PM US ET

Location: 107 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Manjunath (Amit) Pai, PharmD

Professor and Chair
Clinical Pharmacy, University of Michigan
Ann Arbor, MI, United States
Sean Avedissian, PharmD, MSc (he/him/his)

Assistant Professor
Pharmacy Practice and Science
University of Nebraska Medical Center
Omaha, NE, United States

Disclosure(s):

Manjunath (Amit) Pai, PharmD: No financial relationships to disclose

Sean Avedissian, PharmD, MSc: No financial relationships to disclose

At the conclusion of this session, participants will be able to:

explain preclinical approaches that can aid clinical trial designs of antivirals;
describe gaps in knowledge regarding target site pharmacokinetics/pharmacodynamics;
use complex and simple mathematical models to evaluate antiviral exposure-response relationships;
propose a pragmatic framework for individualized antiviral dosing

3:15 PM – 3:40 PM US ET

Experimental Approaches in Antiviral Development: Look Before You Leap
Speaker: Ashley N. Brown, PhD (she/her/hers) – University of Florida
3:40 PM – 4:05 PM US ET

Viral Dynamic Models for SARS-CoV-2 in Early Treatment Trials
Speaker: Akosua Adom Agyeman, PhD – University College London
4:05 PM – 4:30 PM US ET

Ganciclovir for CMV: Can We Do Better?
Speaker: Anne-Grete Martson, PhD – University of Liverpool